1. Oral semaglutide for type 2 diabetes: final policy recommendations Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, December 9, 2019 Subject(s): Diabetes Mellitus, Type 2 -- drug therapyHypoglycemic AgentsUnited States
